GO:0004964 luteinizing hormone receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004964 (luteinizing hormone receptor activity) describes the molecular function of binding luteinizing hormone (lutropin) to initiate intracellular signaling.
• The luteinizing hormone receptor (LHR) is a G protein-coupled receptor encoded by the LHCGR gene; it also binds chorionic gonadotropin (CG) with high affinity.
• LHR activation triggers cAMP/PKA and other signaling cascades that regulate steroidogenesis, ovulation, and spermatogenesis.
• Mutations in LHCGR cause reproductive disorders such as Leydig cell hypoplasia, precocious puberty, and hypergonadotropic hypogonadism.
• LHR trafficking and differential signaling between LH and CG are critical for distinct physiological outcomes.
• CRISPR-based models (knockout, knock-in, point mutation) enable precise dissection of LHR function in health and disease.
Description
Luteinizing hormone receptor activity (GO:0004964) is a molecular function defined as combining with luteinizing hormone (also called lutropin) to initiate a change in cell activity. This activity is mediated by the luteinizing hormone receptor (LHR), a member of the glycoprotein hormone receptor family of G protein-coupled receptors (GPCRs). LHR is primarily expressed in gonadal tissues, including Leydig cells of the testis and granulosa and theca cells of the ovary, where it plays a central role in reproductive physiology. The receptor also binds chorionic gonadotropin (CG) with high affinity, and this dual ligand specificity is important for distinct physiological roles during pregnancy and the menstrual cycle. Research on LHR has been driven by its critical functions in steroidogenesis, ovulation, and spermatogenesis, as well as its involvement in reproductive disorders and certain cancers. Structural studies have revealed the molecular basis of hormone binding and receptor activation, providing insights into how mutations alter receptor function. The differential signaling between LH and CG, influenced by receptor trafficking and glycosylation, has emerged as a key area of investigation. Understanding LHR activity at the molecular level is essential for developing targeted therapies for reproductive diseases and for optimizing assisted reproductive technologies. This article provides a comprehensive overview of GO:0004964, covering its definition, mechanism, key genes, regulation, disease associations, and research methodologies. It is intended for researchers seeking to study LHR function using advanced tools such as CRISPR gene editing and high-throughput screening.
luteinizing hormone receptor activity At A Glance
| GO ID | GO:0004964 |
|---|---|
| GO term | luteinizing hormone receptor activity |
| Ontology | molecular_function |
| Synonym | LHR, LH receptor, lutropin-choriogonadotropic hormone receptor, lutropin receptor |
| Major function | Binding luteinizing hormone to initiate intracellular signaling |
| Gene | LHCGR (luteinizing hormone/choriogonadotropin receptor) |
| Ligands | Luteinizing hormone (LH), chorionic gonadotropin (CG) |
| Signaling pathways | cAMP/PKA, MAPK, and others |
| Physiological roles | Steroidogenesis, ovulation, spermatogenesis |
What Is GO:0004964?
Luteinizing hormone receptor activity (GO:0004964) is the molecular function of specifically binding to luteinizing hormone (lutropin) and thereby initiating a change in cell activity. This activity is intrinsic to the luteinizing hormone receptor (LHR), a cell surface receptor that couples hormone binding to intracellular signal transduction pathways.
Why Is luteinizing hormone receptor activity Important in Cell Biology?
Luteinizing hormone receptor activity is fundamental to reproductive biology and endocrine function. It mediates the actions of LH and CG, which are essential for gonadal development, sex steroid production, and gametogenesis. Dysregulation of LHR signaling is linked to a spectrum of reproductive disorders, including infertility, precocious puberty, and gonadal hypoplasia. Moreover, LHR is a target for therapeutic interventions in assisted reproduction and is implicated in certain cancers, making it a subject of intense research.
• Regulates steroidogenesis in Leydig cells and ovarian follicular cells.
• Triggers ovulation and corpus luteum formation in females.
• Supports spermatogenesis in males through testosterone production.
• Mutations cause Leydig cell hypoplasia, precocious puberty, and hypergonadotropic hypogonadism.
• Differential LH/CG signaling influences pregnancy maintenance and fetal development.
• LHR expression is found in non-gonadal tissues, including lymphocytes, suggesting broader roles.
• LHR is a potential therapeutic target for reproductive cancers.
• Understanding LHR trafficking informs drug design for reproductive disorders.
• Animal models with LHR mutations provide insights into human disease.
• CRISPR screening can identify modulators of LHR signaling.
What Happens During luteinizing hormone receptor activity?
Hormone Binding and Receptor Activation
In simple terms: The hormone LH attaches to the receptor on the cell surface, causing the receptor to change shape and become active.
Luteinizing hormone (LH) binds to the extracellular domain of the luteinizing hormone receptor (LHR), a glycoprotein hormone receptor. This binding induces conformational changes that propagate through the receptor, leading to activation of the associated G protein, primarily Gs, which stimulates adenylyl cyclase to produce cyclic AMP (cAMP). Structural studies have elucidated the detailed architecture of the hormone-receptor complex, revealing how ligand binding triggers receptor activation.
Intracellular Signaling Cascades
In simple terms: Once activated, the receptor turns on a series of signals inside the cell that lead to changes like hormone production.
Activated LHR stimulates multiple signaling pathways, including the cAMP/protein kinase A (PKA) pathway, which is the primary mediator of steroidogenesis. It also activates MAPK/ERK and other pathways that contribute to cell proliferation, differentiation, and gene expression. The differential activation of these pathways by LH versus CG is influenced by receptor trafficking and glycosylation states.
Physiological Responses
In simple terms: The signals lead to the production of sex hormones and the release of eggs or sperm.
In Leydig cells, LHR activation increases testosterone synthesis. In ovarian granulosa and theca cells, it promotes estrogen and progesterone production, and triggers ovulation. These effects are essential for reproductive function. LHR activity also plays a role in non-gonadal tissues, where its function is less understood but may include immune modulation.
Receptor Desensitization and Trafficking
In simple terms: After signaling, the receptor is internalized and either recycled or degraded to prevent overstimulation.
Following activation, LHR undergoes phosphorylation, arrestin recruitment, and internalization. This process, known as desensitization, regulates the duration and intensity of signaling. Receptor trafficking is also a determinant of differential signaling between LH and CG.
Key Genes Involved in GO:0004964 luteinizing hormone receptor activity
The following genes and proteins are key players in luteinizing hormone receptor activity and its signaling network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LHCGR | Encodes the luteinizing hormone receptor | Mutations cause reproductive disorders; target for CRISPR editing |
| LHB | Encodes the beta subunit of luteinizing hormone | Ligand for LHR; knockout models show hypogonadism |
| CGA | Encodes the alpha subunit common to LH, FSH, TSH, and CG | Essential for hormone assembly and secretion |
| CGB | Encodes the beta subunit of chorionic gonadotropin | Ligand for LHR during pregnancy; differential signaling |
| GNAS | Encodes Gs alpha subunit | Mediates LHR signaling to adenylyl cyclase |
| ADCY | Adenylyl cyclase isoforms | Generate cAMP downstream of LHR |
| PRKACA | Catalytic subunit of PKA | Mediates phosphorylation events in LHR signaling |
| ARRB1 | Beta-arrestin 1 | Regulates LHR desensitization and internalization |
| ARRB2 | Beta-arrestin 2 | Regulates LHR desensitization and internalization |
| MAPK1 | ERK2 | Participates in LHR-mediated MAPK signaling |
| MAPK3 | ERK1 | Participates in LHR-mediated MAPK signaling |
| STAR | Steroidogenic acute regulatory protein | Key downstream target of LHR in steroidogenesis |
| CYP11A1 | Cholesterol side-chain cleavage enzyme | Catalyzes first step in steroidogenesis; regulated by LHR |
| HSD3B2 | 3 beta-hydroxysteroid dehydrogenase | Involved in testosterone and progesterone synthesis |
| CYP17A1 | 17 alpha-hydroxylase | Androgen synthesis; regulated by LHR |
| CYP19A1 | Aromatase | Estrogen synthesis; regulated by LHR in granulosa cells |
| FSHR | Follicle-stimulating hormone receptor | Related GPCR; cooperates with LHR in ovarian function |
| TSHR | Thyroid-stimulating hormone receptor | Homologous GPCR; structural insights from TSHR inform LHR |
How Is luteinizing hormone receptor activity Regulated?
Luteinizing hormone receptor activity is regulated at multiple levels. Hormonal regulation includes negative feedback by gonadal steroids on LH secretion. Allosteric modulation of the receptor by small molecules and antibodies has been explored. Receptor trafficking, glycosylation, and interaction with accessory proteins such as arrestins modulate signaling. Additionally, post-translational modifications and dimerization influence receptor function.
luteinizing hormone receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LHCGR | Leydig cell hypoplasia, precocious puberty | Knockout mouse, patient-derived iPSCs |
| LHCGR | Ovarian dysgenesis | Knock-in mouse with patient mutations |
| LHB | Hypogonadism | Knockout mouse |
| CGB | Pregnancy-related disorders | Overexpression models |
| LHCGR | Cancer (testicular, ovarian) | Xenograft models with LHR overexpression |
Reproductive Disorders
Mutations in LHCGR cause a range of reproductive disorders. Inactivating mutations lead to Leydig cell hypoplasia and hypergonadotropic hypogonadism in males, and ovarian dysgenesis in females. Activating mutations cause precocious puberty, particularly in boys. These conditions highlight the critical role of LHR in sexual development and fertility.
Cancer
LHR expression has been detected in certain cancers, including testicular and ovarian tumors. Its role in cancer cell proliferation and steroidogenesis is under investigation, with potential implications for targeted therapy. LHR expression in nonneoplastic and neoplastic lymphocytes suggests a broader role in immune-related neoplasms.
Hair Loss
Recent studies in mice suggest that luteinizing hormone can induce hair loss through TRPC channel-mediated cell aging responses, implicating LHR signaling in female pattern hair loss pathogenesis. This finding expands the physiological relevance of LHR beyond reproduction.
From luteinizing hormone receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of LHR loss on fertility? | LHCGR knockout mouse |
| How do activating mutations cause precocious puberty? | Knock-in mouse with LHCGR point mutation |
| What is the role of LHR in cancer? | LHCGR overexpression in cancer cell lines |
| How does LHR trafficking affect signaling? | Tagged LHR knock-in cell lines |
| What are the structural determinants of ligand binding? | Point mutations in LHCGR extracellular domain |
| Can we identify modulators of LHR signaling? | CRISPR library screening in LHR-expressing cells |
How to Study the luteinizing hormone receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| cAMP assay | Intracellular cAMP levels | Assess LHR activation by ligands |
| Luciferase reporter | Transcriptional activity of CREB | Measure LHR signaling |
| Western blot | Phosphorylation of ERK, PKA substrates | Detect downstream signaling |
| Cryo-EM | 3D structure of receptor-ligand complexes | Understand activation mechanism |
| CRISPR screen | Gene essentiality or regulation | Identify modulators of LHR pathway |
| Flow cytometry | Cell surface LHR expression | Quantify receptor levels |
| Immunohistochemistry | Tissue distribution of LHR | Localize receptor in gonads and other tissues |
CRISPR-Based Genetic Screens
CRISPR knockout and activation screens can identify genes that regulate LHR expression or signaling. These screens are valuable for uncovering novel components of the LHR pathway and potential therapeutic targets.
Structural Biology
Cryo-electron microscopy and X-ray crystallography have been used to determine the structures of LHR and related glycoprotein hormone receptors in complex with hormones and G proteins, providing mechanistic insights.
Signaling Assays
cAMP accumulation, luciferase reporter assays, and phospho-ERK measurements are standard methods to assess LHR activity and downstream signaling in response to LH or CG.
Animal Models
Genetically modified mice, including knockouts and knock-ins, are used to study LHR function in vivo and model human reproductive disorders.
How CRISPR Can Be Used to Study GO:0004964 luteinizing hormone receptor activity
Knockout
CRISPR knockout of LHCGR in cell lines or animal models abolishes LHR activity, enabling studies of its role in steroidogenesis, ovulation, and fertility. Knockout mice exhibit hypogonadism and infertility, mimicking human inactivating mutations.
Point Mutation
Introducing specific point mutations in LHCGR via CRISPR base editing or homology-directed repair allows functional analysis of disease-associated variants. For example, activating mutations that cause precocious puberty can be modeled to study constitutive signaling.
Knock-in
Knock-in of tagged LHR (e.g., HA or GFP) enables real-time tracking of receptor trafficking and localization. This approach helps dissect the differential signaling between LH and CG.
Overexpression
CRISPR activation or lentiviral overexpression of LHCGR in cell lines can amplify LHR signaling for biochemical studies or drug screening. Overexpression models are useful for studying LHR in non-gonadal tissues and cancers.
How EDITGENE Supports luteinizing hormone receptor activity Research
Researchers studying luteinizing hormone receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for luteinizing hormone receptor activity research.
Frequently Asked Questions About luteinizing hormone receptor activity
What is luteinizing hormone receptor activity?
Luteinizing hormone receptor activity (GO:0004964) is the molecular function of binding luteinizing hormone to initiate a change in cell activity, primarily through the LHR receptor.
What genes are involved in luteinizing hormone receptor activity?
The primary gene is LHCGR, which encodes the receptor. Other genes include LHB and CGB (ligands), GNAS, ADCY, and PRKACA (signaling components).
What diseases are associated with luteinizing hormone receptor mutations?
Mutations in LHCGR cause Leydig cell hypoplasia, precocious puberty, and hypergonadotropic hypogonadism.
How does luteinizing hormone receptor signaling work?
LH binds to LHR, activating Gs and adenylyl cyclase to produce cAMP, which triggers PKA and other pathways leading to steroidogenesis and ovulation.
What is the difference between LH and CG binding to LHR?
Both hormones bind LHR, but differential signaling is influenced by receptor trafficking and glycosylation, leading to distinct physiological outcomes.
Can CRISPR be used to study luteinizing hormone receptor activity?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools to dissect LHR function and model human diseases.
What are the research methods to study LHR activity?
Common methods include cAMP assays, luciferase reporters, Western blot, cryo-EM, and CRISPR screens.
Is LHR expressed outside the gonads?
Yes, LHR expression has been found in non-gonadal tissues such as lymphocytes, suggesting broader roles.
What is the role of LHR in hair loss?
Recent mouse studies suggest LH can induce hair loss through TRPC channel-mediated cell aging, implicating LHR in female pattern hair loss.
How can EDITGENE help with LHR research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression models, and library screening services to study LHR function and identify therapeutic targets.
Conclusion
Luteinizing hormone receptor activity (GO:0004964) is a critical molecular function in reproductive biology, mediating the actions of LH and CG to regulate steroidogenesis, gametogenesis, and fertility. Dysregulation of LHR signaling leads to a range of reproductive disorders and has been implicated in cancer and other conditions. Advances in structural biology and CRISPR-based models have deepened our understanding of LHR mechanism and regulation. Continued research using these tools will uncover new therapeutic opportunities and expand our knowledge of LHR in health and disease.
References
- 1. Duan J et al.. 2022. Hormone- and antibody-mediated activation of the thyrotropin receptor.. Nature 609(7928):854-859 PMID: 35940204
- 2. Dufau ML. 1998. The luteinizing hormone receptor.. Annu Rev Physiol 60:461-96 PMID: 9558473
- 3. Lazzaretti C et al.. 2025. Trafficking of luteinizing hormone receptor directs the differential signal activation between luteinizing hormone and chorionic gonadotropin.. Int J Biol Macromol 318(Pt 3):145247 PMID: 40517872
- 4. Duan J et al.. 2021. Structures of full-length glycoprotein hormone receptor signalling complexes.. Nature 598(7882):688-692 PMID: 34552239
- 5. Qiao J et al.. 2019. Diseases caused by mutations in luteinizing hormone/chorionic gonadotropin receptor.. Prog Mol Biol Transl Sci 161:69-89 PMID: 30711030
- 6. Shpakov AO. 2024. Hormonal and Allosteric Regulation of the Luteinizing Hormone/Chorionic Gonadotropin Receptor.. Front Biosci (Landmark Ed) 29(9):313 PMID: 39344322
- 7. Wu CY et al.. 2025. Luteinizing Hormone Induces Murine Hair Loss through Transient Receptor Potential Canonical Channel-Mediated Cell Aging Responses: Implications for Female Pattern Hair Loss Pathogenesis.. J Invest Dermatol 145(12):2989-2997.e7 PMID: 40311867
- 8. Ettinger AM et al.. 2019. Luteinizing hormone receptor expression by nonneoplastic and neoplastic canine lymphocytes.. Am J Vet Res 80(6):572-577 PMID: 31140843
